Eli

FDA rescinds Emergency Use Authorization of Eli Lilly’s ‘bamlanivimab’ monoclonal antibody treatment

WHITE OAK, MD – JULY 20: A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. (Photo by Sarah Silbiger/Getty Images) OAN NewsroomUPDATED 6:20 PM PT – Saturday, April 17, 2021 The FDA has rescinded its Emergency Use Authorization of Eli Lilly’s ‘bamlanivimab,’ …

FDA rescinds Emergency Use Authorization of Eli Lilly’s ‘bamlanivimab’ monoclonal antibody treatment Read More »

Special Report: Insider alleges Eli Lilly blocked her efforts to sound alarms about U.S. drug factory

FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar March 11, 2021 By Marisa Taylor and Dan Levine (Reuters) – On a chilly spring morning in 2019, Amrit Mula arrived in her office at pharmaceutical giant Eli Lilly and …

Special Report: Insider alleges Eli Lilly blocked her efforts to sound alarms about U.S. drug factory Read More »

U.S. gov’t agrees to buy 100K doses of Eli Lilly antibody treatment

A healthcare worker drops blood for a rapid Covid-19 antibody test at the Southside Church of Christ in Los Angeles, California. (Photo by RINGO CHIU/AFP via Getty Images) OAN NewsroomUPDATED 5:00 PM PT – Friday, February 26, 2021 The U.S. government agreed to buy 100,000 doses of Eli Lilly’s COVID antibody therapy. According to that deal, …

U.S. gov’t agrees to buy 100K doses of Eli Lilly antibody treatment Read More »

Eli Lilly to buy gene therapy developer Prevail in about $1 billion deal | One America News Network

FILE PHOTO: Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake December 15, 2020 (Reuters) -Drugmaker Eli Lilly and Co said on Tuesday it would spend about $1 billion to buy Prevail Therapeutics Inc to strengthen its presence in the lucrative field of …

Eli Lilly to buy gene therapy developer Prevail in about $1 billion deal | One America News Network Read More »